Why Philanthropy Matters

-

We’ve all heard the phrase “the system is broken”. Unfortunately, this could be referring to many things – politics, education, law, government, you name it – but the “system” of funding basic cancer research truly is broken.  Watch the news and you will think we are making progress in the fight against cancer – we hear about immunotherapy and nanotechnology, precision medicine, the moon shot, etc.  There are new FDA approvals of new drugs from big pharma, biotech companies going public, venture capital supporting up and coming companies, etc. And yes, we are definitely making progress. But I believe that most people don’t realize that we could accelerate this progress if we put more seed money into the hands of researchers on the front lines. The system really is broken.  And the reality is that philanthropy is critical in our current funding model in order for us to help advance innovation – to help scientists work on discoveries that just don’t exist today. 
 
I’ve spoken to several scientists doing basic cancer research and what I hear is very consistent – they spend 70-80 percent of their time on raising money for their lab, writing grants or seeking donations from private sources. The institutions where the scientists work are not providing full funding for their lab, and this is what I think most people don’t realize. These scientists are under extreme pressure to find money to keep their lab operating. Do we really want our brilliant scientists spending the majority of their time on fundraising? I’d rather they spend 100% of their time in the lab, wouldn’t you?  And,  if you are a cancer scientist, even at a major hospital or university, and you get  funding from a National Institutes of Health (NIH) grant, there is an almost 90% chance you may not get another grant when it expires. Yes, your chance of getting an NIH grant in oncology is about 11%. So the responsibility to keep the lab operating (funded) is on the scientist. I suppose it is like a law firm where you have to provide billable hours to support your position with the firm, but it feels different to me when it is about focusing time in a laboratory. I think we should trust that the scientists need the time to test their ideas.
 
 
All of this was on my mind when I attended the World Medical Innovation Forum in Boston last week. The Forum is a gathering of senior corporate, investor and academic leaders, organized by Partners HealthCare Innovation, a division of Partners HealthCare dedicated to advancing the commercial application of the capabilities of Partners’ academic medical centers. The Forum highlighted topics such as emerging cancer innovations in immunotherapy, epigenetics, early diagnosis, combination therapies, curative drugs, and the role of patients in innovation. The last part of the Forum was a showcase of the most promising cancer technology innovations from around the world — the 12 technologies with the potential to revolutionize cancer treatment and patient care over the next decade called “The Disruptive Dozen.” And this is what got me revved up about how philanthropy really matters if we want to advance these identified promising ideas.
 
 
The bottom line is, there are “disruptive” technologies that have been identified by thought leaders at institutions at this Forum such as Partners Healthcare, Massachusetts General Hospital, Brigham and Women’s Hospital, Dana-Farber Cancer Institute, and Harvard Medical School. The question is, how can we provide the resources to the scientists/researchers behind the scenes to bring these ideas to patients – and the sooner the better? The reality is we need philanthropic support. This is why I am on a mission to educate the public – and those individuals, foundations and companies that have the resources to make a difference – to help bring technologies like the “Disruptive Dozen” to cancer care. I’m grateful for those philanthropists who have already answered the call to support these researchers. People like Sean Parker, thank you.  My goal is to find others who may not be aware of these opportunities to make an impact on the fight against cancer. We are all in this together.
 
#CancerResearchEvangelist

 

Popular posts from this blog

The Power of Community: The White Ribbon Project

-
Image
The Greek meaning of evangelist is "bringing the good news." It's why I call my podcast the Research Evangelist Podcast. I love to share stories about people in life sciences who are doing amazing work to advance cancer research. And it's why The White Ribbon Project has captured my attention. The White Ribbon Project is a grassroots movement of lung cancer patients, advocates, clinicians, researchers friends and families with a mission to change the public perception of lung cancer by spreading awareness that anyone with lungs can get lung cancer. No one deserves lung cancer whether you smoked or not. But lung cancer is not just a smokers disease, as more and more people are getting lung cancer with no smoking history. The White Ribbon Project is proving that the power of a community that cares can be unleashed by individuals who wanted to make a difference - people that didn't set out to start a movement. It's because their story is so sincere and authentic
Read more

Online Cancer Communities and Serendipity

-
Image
I've often told friends that I believe in serendipity. One definition of serendipity is "the occurrence and development of events by chance in a happy or beneficial way." Or even better maybe, "an aptitude for making desirable discoveries by accident." It's like saying "it's a small world." That happens to me a lot, but the world is not small unless you make the effort to actively connect with people and engage in real human conversations. And if you use the online tools available in the way they were meant to work, like Twitter, you can make real human connections by sharing what you care about with the world. Online communities provide opportunities to build authentic connections that can blossom into offline friendships, business relationships and networking. In the online cancer communities, really positive and interesting things happen to me often. I recently made an amazing new connection that came about because of some old connections an
Read more

Meet Ellen Skala: Super Advocate

-
Image
I was in Washington, D.C. recently on Capitol Hill meeting with my representatives in Congress to advocate for federal funding for biomedical research. As I’ve written many times, I believe government agencies like National Institutes of Health (NIH) , National Cancer Institute (NCI) and Department of Defense (DoD) play a critical role in advancing science and making discoveries that impact millions of lives. As a lung cancer survivor, I’ve advocated for cancer research for many years. This time I was on the hill on behalf of the organization I work for,  FRAXA Research Foundation , advocating for Fragile X research on Advocacy Day, an event organized by the National Fragile X Foundation. And I met an advocate that inspired me and reinforced my long-held belief that one person can make a difference. Meet Ellen Skala. Ellen Skala, also referred to as Elle, was on Capitol Hill to advocate that day too. I had spoken with her several times, but I had never met her in person.
Read more